Parvifloron D from Plectranthus strigosus : Cytotoxicity Screening of Plectranthus spp. Extracts
Catarina Garcia, Epole Ntungwe, Ana Rebelo and 12 more
Biomolecules · 2019
doi:10.3390/biom9100616 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The <i>Plectranthus</i> genus is commonly used in traditional medicine due to its potential to treat several illnesses, including bacterial infections and cancer. As such, aiming to screen the antibacterial and cytotoxic activities of extracts, sixteen selected <i>Plectranthus</i> species with medicinal potential were studied. In total, 31 extracts obtained from 16 <i>Plectranthus</i> spp. were tested for their antibacterial and anticancer properties. Well diffusion method was used for preliminary antibacterial screening. The minimum inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) values of the five most active acetonic extracts (<i>P. aliciae</i>, <i>P. japonicus</i>, <i>P. madagascariensis var. “Lynne”</i>, <i>P. stylesii</i>, and <i>P. strigosus</i>) were determined. After preliminary toxicity evaluation on <i>Artemia salina</i> L., their cytotoxic properties were assessed on three human cancer cell lines (HCT116, MCF-7, and H460). These were also selected for mechanism of resistance studies (on NCI-H460/R and DLD1-TxR cells). An identified compound—parvifloron D—was tested in a pair of sensitive and MDR-Multidrug resistance cancer cells (NCI-H460 and NCI-H460/R) and in normal bronchial fibroblasts MRC-5. The chemical composition of the most active extract was studied through high performance liquid chromatography with a diode array detector (HPLC-DAD/UV) and liquid chromatography−mass spectrometry (LC−MS). Overall, <i>P. strigosus</i> acetonic extract showed the strongest antimicrobial and cytotoxic potential that could be explained by the presence of parvifloron D, a highly cytotoxic diterpene. This study provides valuable information on the use of the <i>Plectranthus</i> genus as a source of bioactive compounds, namely <i>P. strigosus</i> with the potential active ingredient the parvifloron D.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.